Company Data
Terns Pharmaceuticals Inc.
Ticker
TERN
Current Price
$27.13 -1.31%
Market Cap
$2.4B
Price Target
Refer to Report
Volume
3.6M
52wk Range
$1.865 - $29.51
Overview
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.